Industry Analysis & Industry Trends
The Pharmaceutical Product Manufacturing industry is dominated by major global pharmaceutical groups, although only a small number are engaged in local manufacture of active pharmaceutical ingredients. An increasing number of firms are limiting their Australian involvement to the later stages of the manufacturing process, such as dispensing, packaging and the fill-and-finish stage. A large number of players also restrict their Australian activities to purely distribution.
As with the global pharmaceutical industry, the local industry is currently contending with the fallout associated with the patent cliff. Between 2011 and 2015, some of the world's highest selling drugs have already lost or are due to lose patent protection... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
The Pharmaceutical Product Manufacturing industry is currently undergoing a process of rationalisation as growth rates drop off compared with the strong growth achieved in the 1990s. During the 1990s, industry revenue grew at an annualised 9.4% while its contribution to the Australian economy gradually increased. However this scenario has since been replaced by one of falling growth rates and marked rationalisation as the industry has been forced to contend with dramatic changes in its operating environment, on both a local and global scale.
Contribution to GDP
The Pharmaceutical Product Manufacturing industry is currently in the mature phase of its life cycle, as evidenced by slowing revenue growth and declining profitability... purchase to read more